Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.75 |
| ▸ | CHEK1 | O14757 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | MAOA | P21397 | 3/20 | 0.58 |
| ▸ | CDC25B | P30305 | 1/20 | 0.55 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.50 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31472931 | 1.00 | GPR3 (0.75) | GPR3CHEK1MEN1KMT2AL3MBTL1 | |
| SCHEMBL472539 | 1.00 | GPR3 (0.75) | GPR3CHEK1MEN1KMT2AL3MBTL1 | |
| SCHEMBL29481 | 0.86 | GPR3 (1.00) | GPR3CHEK1MEN1KMT2AL3MBTL1 | |
| SCHEMBL29387122 | 0.86 | GPR3 (1.00) | GPR3CHEK1MEN1KMT2AL3MBTL1 | |
| SCHEMBL10945035 | 0.82 | MAOA (0.57) | GPR3CHEK1MEN1KMT2AL3MBTL1 | |
| SCHEMBL17954672 | 0.82 | MAOA (0.54) | GPR3CHEK1MEN1KMT2AL3MBTL1 | |
| SCHEMBL12796758 | 0.82 | CHEK1 (0.59) | GPR3CHEK1MEN1KMT2AL3MBTL1 | |
| SCHEMBL16900704 | 0.82 | MEN1 (0.62) | GPR3CHEK1MEN1KMT2AL3MBTL1 | |
| SCHEMBL5972625 | 0.82 | GPR3 (0.52) | GPR3CHEK1MEN1KMT2AL3MBTL1 | |
| SCHEMBL5800591 | 0.82 | CHEK1 (0.59) | GPR3CHEK1MEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3943492-B1 | TADF MATERIALS COMPRISING 4-(3-(2-(10H-PHENOXAZIN-10-YL)PYRIDIN-5-YL)-9H-CARBAZOL-9-YL)BENZONITRILE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN OLEDS | NOCTILUCA S A (PL) | 2024-05-08 | — | — | EP | claimed |
| EP-3669854-B1 | PHOTOPOLYMERIZABLE DENTAL COMPOSITION | G C DENTAL IND CORP (JP) | 2026-04-08 | — | — | EP | disclosed |
| US-12565613-B2 | Quantum dots with donor-acceptor ligands | SHOEI CHEMICAL INC. (JP) | 2026-03-03 | — | — | US | disclosed |
| EP-3825099-B1 | THREE-DIMENSIONAL PRINTING COMPOSITION AND METHOD OF PRODUCING DENTAL ARTICLE | G C DENTAL IND CORP (JP) | 2025-10-22 | — | — | EP | disclosed |
| EP-4586988-A1 | DENTAL PRODUCT WITH REDUCED EXTRUSION FORCES | Solventum Intellectual Properties Company (US) | 2025-07-23 | — | — | EP | disclosed |
| CN-119855576-A | Dental product with reduced extrusion force | 舒万诺知识产权公司 | 2025-04-18 | — | — | CN | disclosed |
| CN-116507309-B | Dental pH sensitive microcapsules | 舒万诺知识产权公司 | 2025-03-25 | — | — | CN | disclosed |
| EP-4514304-A1 | DENTAL COMPOSITION CONTAINING A RESORCINOL OR CATECHOL MOIETY CONTAINING COMPONENT AND USE THEREOF | Solventum Intellectual Properties Company (US) | 2025-03-05 | — | — | EP | disclosed |
| CN-119136772-A | Dental composition comprising a component comprising resorcinol or catechol moieties and uses thereof | 舒万诺知识产权公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-119072457-A | Glass composition | 株式会社GC | 2024-12-03 | — | — | CN | disclosed |
| WO-2022229739-A1 | CALCIUM AND FLUORINE IONS RELEASING DENTAL COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-11-03 | — | — | WO | disclosed |
| WO-2022229734-A1 | INITIATOR SYSTEM WITH POLYMERIZABLE THIOUREA COMPONENT, DENTAL COMPOSITION AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-11-03 | — | — | WO | disclosed |
| US-11433005-B2 | Dental filling material and dental polymerizable composition | GC CORPORATION (JP) | 2022-09-06 | — | — | US | disclosed |
| WO-2022168429-A1 | DENTAL ADHESIVE COMPOSITION | 株式会社ジーシー | 2022-08-11 | — | — | WO | disclosed |
| WO-2022118125-A1 | PH-SENSITIVE MICROCAPSULE FOR DENTAL USE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-06-09 | — | — | WO | disclosed |
| EP-3982905-A1 | PROCESS OF TAKING A DENTAL IMPRESSION WITH A RADIATION-CURABLE COMPOSITION CONTAINING MERCAPTO-FUNCTIONAL POLYORGANOSILOXANES AND VQM RESINS | 3M Innovative Properties Company (US) | 2022-04-20 | — | — | EP | disclosed |
| EP-3980175-A1 | MICROCAPSULE WITH A POROUS OR HOLLOW CORE AND A SHELL CONTAINING A COMPONENT RELEASING GAS UPON CONTACT WITH AN ACID | 3M Innovative Properties Company (US) | 2022-04-13 | — | — | EP | disclosed |
| CN-109942635-B | Phenyl tricarbazole spiro derivative, preparation method and application thereof, and electronic device | 苏州大学 | 2022-04-12 | — | — | CN | disclosed |
| CN-106535861-B | Two-component self-adhesive dental composition, method of making and using the same | 3M创新有限公司 | 2022-02-08 | — | — | CN | disclosed |
| CN-114008093-A | Antimicrobial polymer particles, compositions and articles | 株式会社GC | 2022-02-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565613-B2 | Quantum dots with donor-acceptor ligands | HCCS, FDPS, FTH1 | GPR3 1277/4885CHEK1 4064/4885MEN1 4437/4885 |
| US-11433005-B2 | Dental filling material and dental polymerizable composition | CAD, MEP1A, ESD | GPR3 2684/4885CHEK1 3524/4885MEN1 3073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.